La cadena de opciones muestra datos clave de las opciones de acciones de Avenue Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Avenue Therapeutics..

Avenue Therapeutics (NASDAQ:ATXI) Bolsa, Cadena de Opciones

Avenue Therapeutics

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AGMH

ANTE

ARBE

ARLO

ATXI

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FINV

GNPX

GRAB

HNRG

HROW

HYPR

KTCC

VRPX

VSTM

Las acciones de Harrow subieron un 23,1% en el premercado. Descubre qué otras compañías están ganando y perdiendo antes de la apertura.

Las acciones de Harrow (HROW) se disparan un 23%; aquí están 20 acciones que se mueven en el premercado

Avenue Therapeutics Inc

U.S. stock futures advanced on Wednesday ahead of the Federal Open Market Committee&#8217;s (FOMC) decision on the interest rates. Futures of all four benchmark indices were higher in premarket trading.
On Tuesday, the stocks plunged after a two-day rally as the Magnificent 7 stocks dragged the indices down. Nvidia Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) GTC AI Conference failed to ignite a rally despite a slew of announcements.
The two-day FOMC meeting began on Tuesday, and the Federal Reserve Chairman Jerome Powell is expected to announce its decision during a press conference on Wednesday afternoon.
The 10-year Treasury yield stood at 4.29%, while the two-year yield was at 4.05%. According <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">to</a> the CME Group's FedWatch tool, there is a 99% chance that the Federal Reserve will keep interest rates unchanged.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.16%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.26%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.02%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.28%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Wednesday. The SPY was up 0.26% to $562.46, and the QQQ advanced 0.35% to $476.22, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Technology, communication services, and consumer discretionary sectors led U.S. stock declines on Tuesday, with the Nasdaq Composite falling roughly 300 points.
Specifically, Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) dropped about 4%, and Nvidia Corp. fell over 3%.
The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) also saw a decline exceeding 1%. In contrast, energy and healthcare stocks rose, defying the broader market&#8217;s downward trend.
Economic data showed that U.S. import prices increased by 0.4% in February, exceeding expectations, while export prices rose 0.1%. The U.S. industrial production also surpassed estimates, increasing by 0.7% in February.
The Nasdaq 100 index continues to be in the correction zone as it was still 12.33% lower from its previous high. While Dow Jones was 7.75% lower, S&amp;P 500 declined 8.67% from their respective 52-week highs.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-1.71%</td>
<td>17,504.12 </td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.07%</td>
<td>5,614.66</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.62%</td>
<td>41,581.31</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.89%</td>
<td>2,049.94</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
"No rate change is expected," noted senior economist at WisdomTree, Jeremy Siegel ahead of the Federal Reserve&#8217;s decision, adding that the dot plot will be updated. The market is pricing in two rate cuts this year, he says, but he's "not convinced that the Fed will fully signal that just yet."
Furthermore, Siegel anticipates Powell will face intense scrutiny regarding declining market sentiment and inflation concerns.
He believes market direction hinges on the tariff situation; further escalation by President Donald Trump could trigger a significant downturn, potentially a &#8220;bear market&#8221;. Regarding Big Tech, Siegel argues current valuations, excluding Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), are high but not bubble-like, unlike the 2000 tech boom.
&#8220;For now, tariffs remain the dominant market force. The path forward depends on how Trump navigates trade policy—any softening would be bullish for equities, while continued escalation would put further downside pressure on stocks,&#8221; Siegel added.
&#8220;We don't expect any surprises at this week&#8217;s FOMC meeting, with the Fed likely holding the federal funds rate in the 4.25% to 4.5% range,&#8221; said Collin Martin, director, of fixed income strategy at the Schwab Center for Financial Research
&#8220;With growth concerns now making the most headlines, Fed Chairman Powell will likely be asked about the balance of risks given that all of the uncertainty out there could weigh on the labor market. We still expect rate cuts later this year, likely in the second half,&#8221; said Martin
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Wednesday:
<ul>
<li>FOMC will announce its decision on interest rates at 2:00 p.m., and Federal Reserve Chairman Jerome Powell will address a press conference at 2:30 p.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Signet Jewelers Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) was up 0.31% in premarket on Wednesday ahead of its earnings before the opening bell. Analysts expect earnings of $6.25 per share on revenue of $2.33 billion.</li>
</ul>
<ul>
<li>Williams-Sonoma Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) advanced 1.17% as Wall Street expects it to report earnings of $2.93 per share on revenue of $2.35 billion before the opening bell.</li>
</ul>
<ul>
<li>Five Below Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) rose 1.26% ahead of its earnings after the closing bell. Analysts expect earnings of $3.38 per share on revenue of $1.39 billion.</li>
</ul>
<ul>
<li>Healthequity Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) slumped 13.09% after it posted downbeat earnings for its fourth quarter on Tuesday.</li>
</ul>
<ul>
<li>StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) jumped 8.02% after reporting better-than-expected fourth-quarter earnings and sales results.</li>
</ul>
<ul>
<li>Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) was 2.01% higher after it announced an AI server lineup with new Nvidia GPU support.</li>
</ul>
<ul>
<li>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) gained 1.06% ahead of the second day of the GTC AI conference.</li>
</ul>
<ul>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) climbed 2.96% after receiving approval for rolling out its first Robotaxi in California.</li>
</ul>
<ul>
<li>TEN Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) surged 33.63% after it announced that it would initiate a $1 million stock repurchase program on March 17, 2025, with no set end date, funded by operating cash and subject to market conditions.</li>
</ul>
<ul>
<li>5E Advanced Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEAM#NASDAQ">FEAM</a>) plunged 20.72% after it announced a resale of up to 20.63 million common shares by stockholders; the company will receive no proceeds and will cover all the expenses.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 0.63% to hover around $66.33 per barrel.
The gold spot index was down by 0.12% to $3,030.36 per ounce. Its last record high was at $3,045.39 per ounce. The Dollar Index was up by 0.35% at the 103.608 level.
Asian markets closed mixed on Wednesday with China&#8217;s CSI 300, South Korea's Kospi, Hong Kong's Hang Seng, and India's S&amp;P BSE Sensex advancing in trade. Japan's Nikkei 225, and Australia's ASX 200 index declined. European markets were also mixed in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44392370/nvidia-destroys-420-billion-of-investor-wealth-since-deepseek-launch-valuation-hits-a-29-month-low-as-gtc-fails-to-ignite-stock">Nvidia Loses $420 Billion In Market Capitalization Since DeepSeek Launch, Valuation Hits A 29-Month Low As GTC Fails To Ignite Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Government

Market Summary

Futures

Federal Reserve

FEAM

FIVE

NVDA

PLTR

SMCI

STNE

TSLA

XHLD

US Stocks Likely To Open Higher Ahead Of FOMC Decision: 'Tariffs Remain The Dominant Market Force' Amid Rising Economic Uncertainty, Says Expert

On Tuesday, NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) disclosed that it is establishing the NVIDIA Accelerated Quantum Research Center (NVAQC) in Boston to drive <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44384079/nvidia-to-build-accelerated-quantum-computing-research-center" rel="noreferrer noopener">advancements in quantum computing</a>.
The center will integrate quantum hardware with AI supercomputers, enabling accelerated quantum supercomputing. NVAQC aims to tackle key challenges like qubit noise and transform experimental quantum processors into practical solutions.
Apart from this, the company announced several collaborations with industry players.
The company, along with Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google, unveiled new AI initiatives to expand access, accelerate development, and transform industries <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44383986/nvidia-alphabet-and-google-collaborate-on-the-future-of-agentic-and-physical-ai" rel="noreferrer noopener">like healthcare, manufacturing, and energy</a>.
Using NVIDIA Omniverse, Cosmos, and Isaac platforms, teams from Google DeepMind, Isomorphic Labs, Intrinsic, and X&#8217;s Tapestry will share key milestones at the NVIDIA GTC AI conference.
Additionally, Google Cloud will be among the first to adopt NVIDIA&#8217;s newly announced GB300 NVL72 rack-scale solution and RTX PRO 6000 Blackwell Server Edition GPU to support AI research and production.
Apart from this, NVIDIA announced a collaboration with General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) to develop next-generation vehicles, factories, and robots powered by AI,<a href="https://www.benzinga.com/pressreleases/25/03/g44382467/general-motors-and-nvidia-collaborate-on-ai-for-next-generation-vehicle-experience-and-manufacturi" target="_blank" rel="noreferrer noopener"> simulation, and accelerated computing</a>.
Related Read: <a href="https://www.benzinga.com//node/44389027" target="_blank" rel="noreferrer noopener">Tesla Takes Another Hit With Nvidia, GM Self-Driving Partnership</a>
Also, NVIDIA partnered with GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) to drive innovation in autonomous medical imaging, <a href="https://www.benzinga.com/pressreleases/25/03/g44384002/nvidia-and-ge-healthcare-collaborate-to-advance-the-development-of-autonomous-diagnostic-imaging-w" target="_blank" rel="noreferrer noopener">focusing on X-ray and ultrasound technologies</a>.
By integrating AI, these systems will enhance automation in patient positioning, image scanning, and quality assessment, streamlining complex workflows in healthcare.
Additionally, NVIDIA disclosed a collaboration with International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44384548/ibm-taps-nvidia-ai-data-platform-technologies-to-accelerate-ai-at-scale" rel="noreferrer noopener">to enhance enterprise AI capabilities</a>.
IBM plans to integrate the NVIDIA AI Data Platform reference design to optimize generative AI workloads.
The company&#8217;s initiatives include content-aware storage for IBM Fusion, expanded watsonx integrations, and new IBM Consulting services with NVIDIA to accelerate AI innovation.
Also, CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) announced new AI-driven cybersecurity innovations using NVIDIA AI software, doubling detection triage speed while <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44384579/crowdstrike-collaborates-with-nvidia-to-advance-agentic-ai-in-cybersecurity-pioneer-testing-of-nvi" rel="noreferrer noopener">cutting compute resource usage by 50%</a>.
This collaboration enhances automation, real-time decision-making, and precision, setting a new standard for AI-powered security.
Meanwhile, KFC parent Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) partnered with NVIDIA to <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44384739/yum-brands-to-accelerate-ai-innovation-in-an-industry-first-collaboration-with-nvidia" rel="noreferrer noopener">revolutionize AI in the restaurant industry</a>.
As NVIDIA&#8217;s first AI restaurant partner, Yum! will leverage cutting-edge AI technologies across its 61,000+ locations worldwide.
Additionally, NVIDIA revealed partnerships with T-Mobile, MITRE, Cisco, ODC (a Cerberus Capital Management portfolio company), and Booz Allen Hamilton to advance the research and development of AI-native wireless <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44382462/nvidia-and-telecom-industry-leaders-to-develop-ai-native-wireless-networks-for-6g" rel="noreferrer noopener">network hardware, software, and architecture for 6G</a>.
Investors can gain exposure to the stock via&nbsp;GraniteShares 2x Short NVDA Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVD#NASDAQ">NVD</a>) and EA Series Trust Strive U.S. Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOC#NYSE">SHOC</a>).
Price Action: NVDA shares are up 1.45% at $117.10 premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/03/44390580/nvidia-just-unveiled-a-humanoid-ai-brain-which-allows-robots-to-think-slow-jensen-huang-says-this-could-very-well-likely-be-the-largest-industry-of-all" target="_blank" rel="noreferrer noopener">Nvidia Just Unveiled A Humanoid AI Brain Which Allows Robots To Think Slow — Jensen Huang Says, &#8216;This Could Very Well Likely Be The Largest Industry Of All&#8217;</a></li>
</ul>
Image via Shutterstock.

Large Cap

Contracts

CRWD

GEHC

GOOG

EA Series Trust Strive U.S. Semiconductor ETF

SHOC

NVIDIA Teams Up with GE, Google, IBM, And CrowdStrike To Redefine AI And Quantum Technology

HC Wainwright &amp; Co. analyst Oren Livnat reiterates Trevi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) with a Buy and maintains $12.5 price target.

Price Target

Reiteration

Analyst Ratings

TRVI

HC Wainwright & Co. Reiterates Buy on Trevi Therapeutics, Maintains $12.5 Price Target

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates XOMA Royalty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>) with a Buy and maintains $104 price target.

XOMA

HC Wainwright & Co. Reiterates Buy on XOMA Royalty, Maintains $104 Price Target

ATGL

Ab Dao Has Announced A Strategic Partnership With Alpha Technology Group Which Will Integrate Their Respective Strengths To Drive The Innovative Application And Adoption Of Artificial Intelligence And Blockchain Technology Across Supply Chain Management, Enterprise Operations, And The Internet Of Things

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates OmniAb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OABI#NASDAQ">OABI</a>) with a Buy and maintains $11 price target.

OABI

HC Wainwright & Co. Reiterates Buy on OmniAb, Maintains $11 Price Target

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) with a Buy and maintains $30 price target.

OLMA

HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $30 Price Target

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Galiano Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GAU#AMEX">GAU</a>) with a Buy and maintains $2.8 price target.

HC Wainwright & Co. Reiterates Buy on Galiano Gold, Maintains $2.8 Price Target

HC Wainwright &amp; Co. analyst Amit Dayal reiterates REE Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REE#NASDAQ">REE</a>) with a Buy and maintains $15 price target.

HC Wainwright & Co. Reiterates Buy on REE Automotive, Maintains $15 Price Target

Shares of StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter <a href="https://www.benzinga.com/quote/STNE/earnings">earnings and sales results</a>.
StoneCo shares jumped 8% to $10.64 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Leishen Energy Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSE#NASDAQ">LSE</a>) gained 90% to $14.31 in pre-market trading after jumping over 46% on Tuesday. The company recently reported FY24 financial results.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) rose 35.4% to $0.1760 in pre-market trading after the company announced positive results from a beagle dog dose range-finding study.</li>
<li>TEN Holdings, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) gained 34% to $0.7839 in pre-market trading. TEN Holdings shares jumped 18% on Tuesday after the company announced a $1 million stock repurchase program.</li>
<li>Aterian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) gained 27% to $2.68 in pre-market after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Bowen Acquisition Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOWN#NASDAQ">BOWN</a>) gained 24% to $5.43 in pre-market trading after jumping 5% on Tuesday.</li>
<li>CARGO Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) gained 21.1% to $4.60 in pre-market trading after the company suspended CRG-023 &amp; allogeneic platform and initiated 90% workforce reduction.</li>
<li>Hillenbrand, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) gained 17.3% to $29.29 in pre-market trading.</li>
<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) rose 11.8% to $1.32 in pre-market trading after dipping 23% on Tuesday.</li>
<li>CNS Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) rose 10.4% to $3.92 after surging 16% on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>FST Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBSX#NASDAQ">KBSX</a>) fell 23.1% to $4.22 in pre-market trading after gaining 310% on Tuesday.</li>
<li>5E Advanced Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEAM#NASDAQ">FEAM</a>) shares fell 21.2% to $3.08 in pre-market trading after gaining 5% on Tuesday.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) fell 18.5% to $0.2012 in pre-market trading after gaining around 22% on Tuesday. Starbox Group company received staff determination notice from Nasdaq.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) declined 16.1% to $26.50 in pre-market trading after climbing 70% on Tuesday.</li>
<li>OSR Holdings, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>) dipped 15.5% to $1.51 in pre-market trading after jumping 34% on Tuesday.</li>
<li>Turkcell Iletisim Hizmetleri A.S. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKC#NYSE">TKC</a>) shares tumbled 14.8% to $6.43 in pre-market trading.</li>
<li>HealthEquity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) shares fell 14.7% to $86.68 in pre-market trading after the company reported worse-than-expected quarterly earnings results.</li>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) shares dipped 13% to $17.87 in pre-market trading following weak quarterly sales.</li>
<li>Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) fell 9.4% to $2.79 in today's pre-market trading after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Waterdrop Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) fell 6.5% to $1.30 in pre-market trading after declining around 5% on Tuesday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44375233/top-3-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

ABSI

ATER

BOWN

CNSP

CRGX

INTZ

KBSX

OSRH

STBX

TNXP

Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

ABTS

Abits Announced That Its Wholly Owned Subsidiary Secured A $3.0M Loan From An Unrelated Third Party To Fund The Purchase Of New Antminer S19XP Machines For Its New Operational Expansions In Memphis, Tennessee

DNUT

Krispy Kreme Introduced A New Edition Of Its Popular Annual Chocomania Collection – Three New Doughnuts And A Returning Fan Favorite, All Featuring Melt-in-your-mouth Krispy Kreme Doughnuts With Delectable Hershey's Milk Chocolate Icing

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(2.60) per share. This is a 91.94 percent increase over losses of $(32.27) per share from the same period last year. The company reported $14.89 million in sales this quarter. This is a 3.19 percent decrease over sales of $15.38 million the same period last year.

Earnings

American Strategic Q4 2024 GAAP EPS $(2.60) Up From $(32.27) YoY

Macro Economic Events

Econ #s

Economics

Eurozone Wages For Q4 (YoY) 4.10% Vs. 4.30% (Revised) Prior

BEEM

Beam Global Announced That Together With Zero Motorcycles It Will Demonstrate The Beampatrol And Zero Motorcycles DSR/X And FX Product Bundles To Military, Law Enforcement, First Responder And Civilian Motorcycle Enthusiasts

Eurozone Consumer Price Index (YoY) For February 2.3% Vs. 2.4% Est.; 2.5% Prior

Eurozone Consumer Price Index (MoM) For February 0.4% Vs. 0.5% Est.; -0.3% Prior

Eurozone Core Consumer Price Index (YoY) For February 2.6% Vs. 2.6% Est.; 2.7% Prior

TransUnion Canada Is Helping Expand Credit Access For New Canadians And Those New To The Credit Market By Providing A Broader And More Comprehensive View Of A Person's Payment Behaviour And Creditworthiness With Truvision Trended Risk Score

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(2.60) per share. The company reported $14.89 million in sales this quarter. This is a 3.19 percent decrease over sales of $15.38 million the same period last year.

American Strategic Q4 2024 Sales $14.89M Down From $15.38M YoY

Press Releases

Avenue Therapeutics Announces Reverse Stock Split

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Avenue Therapeutics to Participate in Upcoming Investor Conferences

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Comments

Avenue Therapeutics

Avenue Therapeutics (ATXI) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL